About Instapill Private Limited
Data last updated:
Instapill Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Tenshi Pharmaceuticals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2007PTC042337. Its GSTIN is 29AABCH8821J1ZA (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25.58 Cr and a paid-up capital of ₹18.64 Cr. It was formerly known as Higher Pharmatech Private Limited. It is led by directors including Ankit Gupta (Whole-Time Director) and Guruswamy Pendyala (Whole-Time Director).
Its last annual general meeting (AGM) was held on 16 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 46 1st Phase KIADB Industrial Area Harohalli Kanakapura, Bangalore, Karnataka, India – 562112.
As per the financials filed for FY 2025, the company reported a revenue of ₹100.92 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹83.7 Cr (net margin -82.9%) and EBITDA of -₹24.31 Cr (EBITDA margin -24.1%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 91% over five years.
The company has about 161 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Triphase Pharmaceuticals and Tenshi Life Sciences. As per MCA filings, the company has open charges of ₹232.46 Cr and satisfied charges of ₹190.85 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tenshi.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No 46 1st Phase KIADB Industrial Area Harohalli Kanakapura, Bangalore, Karnataka, India – 562112
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Name History of Instapill Private Limited
Instapill has undergone 2 name changes throughout its history. The company was previously known as Higher Pharmatech Private Limited, and Instapill Private Limited. The current legal name is Instapill Private Limited.
| Company Name | Status |
|---|---|
| Instapill Private Limited | Current |
| Higher Pharmatech Private Limited | Previous |
Associated Brands with Instapill Private Limited
Instapill operates two associated brands: Triphase Pharmaceuticals and Tenshi Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. | triphasepharma.com | |
| Delivers advanced finished dosage pharmaceuticals using global infrastructure and quality systems. | tenshi.co.in |
Competitors & Alternatives of Instapill Private Limited
Brands and companies operating in the same space as Instapill Private Limited include The Good Bug, Pendulum, Concord Biotech and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 The Good Bug | Synbiotic supplements and fermented products for gut health are provided. | Mumbai, India | 2021 |
 Pendulum | Pendulum is focused on developing advanced probiotic solutions. | San Francisco, United States | 2012 |
 Concord Biotech | APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India | 2000 |
 BDR Pharmaceuticals Internationals | APIs and finished products are developed and manufactured. | Mumbai, India | 2003 |
 Almac Group | Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom | 2001 |
 OptiBiotix Health | Microbial strains are developed for treating human metabolic diseases. | York, United Kingdom | 2012 |
 Indoco Remedies | APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India | 1947 |
 Pharmaceutics International | Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States | 1994 |
 Aurobindo Pharma | Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India | 1986 |
 Seqens | Contract manufacturing services for small molecules and peptides are provided. | Ecully, France | 2003 |
Business Activity of Instapill Private Limited
The main business activity of Instapill is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Instapill Private Limited
Instapill Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Deloitte Haskins & Sells LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Instapill Private Limited
Instapill has 5 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankit Gupta Also directs: AI Cue Capital LLP, Dvise Medtech Private Limited, Karuna Healthcare Group Private Limited and 2 more | Whole-Time Director | 11 Feb 2025 | 1 Years 7 Months | Current |
| Venkataraman Subramanian Iyer Also directs: Areco Leafware LLP | Director | 02 Apr 2007 | 19 Years 6 Months | Current |
| Rajashri Santosh Kumar Ojha Also directs: Fermenta Biotech Limited, Raaj Gprac Private Limited | Director | 11 Feb 2025 | 1 Years 7 Months | Current |
| Gopakumar Gopalan Nair Also directs: Gnanlex Associates LLP, Gnanlex Hermeneutics Private Limited | Director | 11 Feb 2025 | 1 Years 7 Months | Current |
| Guruswamy Pendyala | Whole-Time Director | 28 Apr 2017 | 9 Years 5 Months | Current |
Financials of Instapill Private Limited FY 2025 filings available
Instapill Private Limited reported revenue of ₹100.92 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Instapill Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 91% over five years, including 11% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Instapill Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹24.31 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹83.7 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Instapill Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -24.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -82.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Instapill are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Instapill Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Instapill Private Limited
Instapill has 2 associated companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
Charges & Borrowings of Instapill Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2025 | Others | ₹60 Cr | Open |
| 13 Oct 2025 | Others | ₹95 Cr | Open |
| 09 Oct 2025 | Others | ₹10 Cr | Open |
| 22 Jul 2025 | Hdfc Bank Limited | ₹32.21 Lakh | Open |
| 24 May 2024 | Hdfc Bank Limited | ₹26.81 Lakh | Open |
Total charge records: 14 View all charges
Employees and EPFO Compliance at Instapill Private Limited
Instapill Private Limited has a workforce of 161 employees as of Aug 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Instapill Private Limited
Instapill has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCH8821J1ZA | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Instapill Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Instapill Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Instapill Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Instapill Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Instapill Private Limited
Recent News on Instapill Private Limited
Frequently Asked Questions about Instapill Private Limited
Instapill is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 April 2007 (19+ years old) and is registered under CIN U24230KA2007PTC042337.
Instapill reported revenue of ₹100.92 Cr for FY 2025 (up 11% YoY).
Instapill has 5 current directors:
- Ankit Gupta - Whole-Time Director
- Guruswamy Pendyala - Whole-Time Director
- Venkataraman Subramanian Iyer - Director
- Rajashri Santosh Kumar Ojha - Director
- Gopakumar Gopalan Nair - Director
Instapill reported a net loss of ₹83.7 Cr (net margin -82.9%) and EBITDA of -₹24.31 Cr (EBITDA margin -24.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Instapill is 25% over three years and 91% over five years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Instapill is 29AABCH8821J1ZA, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Instapill is U24230KA2007PTC042337. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Instapill was incorporated on 02 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Bangalore.
Instapill can be reached through the website tenshi.co.in. Its registered office is in Bangalore, Karnataka, India.